Bulletin
Investor Alert

New York Markets Open in:

Allakos Inc.

NAS: ALLK

GO
/marketstate/country/us

Before the Bell

 --Real time quotes

May 27, 2022, 8:06 a.m.

/zigman2/quotes/203639566/composite

$

2.72

Change

+0.06 +2.26%

Volume

Volume 1,763

Real time quotes

/zigman2/quotes/203639566/composite

Previous close

$ 2.66

$ 2.66

Change

+0.04 +1.53%

Day low

Day high

$2.59

$2.75

Open

52 week low

52 week high

$2.58

$112.87

Open

Adam L. Tomasi

Dr. Adam L. Tomasi is a President & Chief Operating Officer at Allakos, Inc. and an Independent Director at LifeSci Acquisition III Corp. He is on the Board of Directors at Attune Pharmaceuticals, Inc. and LifeSci Acquisition III Corp. Dr. Tomasi was previously employed as a Chief Scientific Officer by ZS Pharma, Inc., a Principal by Alta Partners Management Corp., a Medicinal Chemist by Cytokinetics, Inc., and a Medicinal Chemist by Gilead Sciences, Inc. He received his undergraduate degree from the University of California, Berkeley, an MBA from MIT Sloan School of Management and a doctorate degree from the University of California, Irvine.

Transactions

Date Shares Transaction Value
03/02/2022 5,582   Derivative/Non-derivative trans. at $5.38 per share. 30,032
02/25/2022 344,060   Award at $0 per share. 0
12/02/2021 13,067   Derivative/Non-derivative trans. at $78.69 per share. 1,028,243
12/01/2021 33,362   Award at $0 per share. 0
09/02/2021 2,346   Derivative/Non-derivative trans. at $91.66 per share. 215,035
08/31/2021 64,148   Derivative/Non-derivative trans. at $4.31 per share. 276,477
06/15/2021 20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
06/15/2021 20,000   Disposition at $91.03 per share. 1,820,600
06/14/2021 20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
06/14/2021 20,000   Disposition at $91.62 per share. 1,832,400
06/07/2021 2,487   Disposition at $92.03 per share. 228,879
06/04/2021 642   Disposition at $90.26 per share. 57,947
06/03/2021 1,777   Derivative/Non-derivative trans. at $92.2 per share. 163,840
05/12/2021 20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
05/12/2021 20,000   Disposition at $99.23 per share. 1,984,600
05/11/2021 20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
05/11/2021 20,000   Disposition at $97.79 per share. 1,955,800
05/10/2021 20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
05/10/2021 20,000   Disposition at $96.02 per share. 1,920,400
04/14/2021 20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
04/14/2021 20,000   Disposition at $107.77 per share. 2,155,400
04/13/2021 20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
04/13/2021 20,000   Disposition at $103.08 per share. 2,061,600
04/12/2021 20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
04/12/2021 20,000   Disposition at $104.4 per share. 2,088,000
03/10/2021 20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
03/10/2021 20,000   Disposition at $121.78 per share. 2,435,600
03/09/2021 20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
03/09/2021 20,000   Disposition at $121.78 per share. 2,435,600
03/08/2021 20,000   Derivative/Non-derivative trans. at $0.69 per share. 13,800
03/08/2021 20,000   Disposition at $122.78 per share. 2,455,600
03/03/2021 3,189   Disposition at $113.56 per share. 362,143
03/02/2021 1,717   Derivative/Non-derivative trans. at $117.82 per share. 202,296
12/29/2020 5,416   Derivative/Non-derivative trans. at $4.31 per share. 23,342
12/02/2020 8,825   Derivative/Non-derivative trans. at $99.04 per share. 874,028
12/01/2020 78,500   Award at $0 per share. 0
11/29/2019 78,500   Award at $0 per share. 0

Officers and Executives

Dr. Robert Alexander
Chief Executive Officer & Director
Dr. Adam L. Tomasi
President & Chief Operating Officer
Mr. Harlan Baird Radford
Chief Financial Officer
Dr. Ruby Casareno
Vice President-Technical Operations
Dr. Craig Paterson
Chief Medical Officer
Mr. Roland K. Winger
Senior Vice President
Mr. Meg Fitzgerald
Secretary, Chief Compliance Officer & Senior VP
Dr. Sally D. Bolmer
Vice President-Regulatory Affairs & Development
Mr. Alex Schwartz
Vice President-Investor Relations
Mr. Daniel S. Janney
Chairman
Dr. John P. McKearn
Independent Director
Mr. Steven P. James
Independent Director
Mr. Paul E. Walker
Independent Director
Mr. Robert E. Andreatta
Independent Director
Link to MarketWatch's Slice.